Literature DB >> 4057308

Acute tetrachloroethylene poisoning--blood elimination kinetics during hyperventilation therapy.

C Köppel, I Arndt, U Arendt, P Koeppe.   

Abstract

After ingestion of 12-16 g tetrachloroethylene, a 6-year-old boy was admitted to the clinic in coma. In view of the high initial tetrachloroethylene blood level, hyperventilation therapy was performed. Under this therapeutic regimen, the clinical condition of the patient improved considerably. The tetrachloroethylene blood level profile which was determined under hyperventilation therapy could be computer-fitted to a two-compartment model. Elimination of tetrachloroethylene from the blood compartment occurred via a rapid and a slow process with half-lives of 30 min and 36 hours, respectively. These values compared favourably with the half-lives of 160 min and 33 hours under normal respiratory conditions. During hyperventilation therapy, the relative contribution to the fast elimination process increased from 70% for physiological minute volume to 99.9%. A minor fraction of the ingested dose was excreted with the urine (integral of 1% during the first 3 days). In contrast to previous results, trace amounts of unchanged tetrachloroethylene were detected in the urine besides trichloroacetic acid and trichloroethanol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4057308     DOI: 10.3109/15563658508990621

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  2 in total

1.  Acute trichloroethylene poisoning with additional ingestion of ethanol--concentrations of trichloroethylene and its metabolites during hyperventilation therapy.

Authors:  C Köppel; H J Lanz; K Ibe
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 2.  The sources, fate, and toxicity of chemical warfare agent degradation products.

Authors:  N B Munro; S S Talmage; G D Griffin; L C Waters; A P Watson; J F King; V Hauschild
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.